MetaCap

Genmab A/S Statistics

NASDAQ: GMABHealth CareBiotechnology: Pharmaceutical PreparationsUSD

50.60-0.75 (-1.46%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Genmab A/S by the numbers

Genmab A/S has a market capitalization of $31.20 billion based on 616.59M shares outstanding. Its trailing P/E ratio is 43.2, above the 5-company peer median of 20.9, and its forward P/E is 32.0. The stock trades 17.7% above its 50-day average and 58.1% above its 200-day average.

Average daily trading volume is 4.18M shares, or about $211.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

GMAB valuation vs. peer median

GMAB compared with the median of 8 peer companies
MetricGMABPeer medianDifference
Market cap$31.20B$29.51B+6%
P/E (TTM)43.220.9+107%
Forward P/E32.014.5+121%
Avg. volume4.18M3.15M+33%

Peer median across 8 companies: INSM, ZTS, ROIV, UTHR, RPRX, VTRS, ALNY, ONC.

Valuation

Market cap
$31.20B
Price / sales (latest FY)
8.39

Price and trading

Previous close
51.35
Open
51.61
Day range
50.24 – 51.72
52-week range
23.62 – 59.97
52-week change
+66.17%
Beta
—
Volume
2.90M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
31.20B
Pe
43.25
Forward Pe
32.03
Eps
1.17
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
59.97
Week52 Low
23.62
Avg Volume
4.18M
Shares Outstanding
616.59M
Ma50
42.98
Ma200
32.01
Earnings Date
Nov 5, 2026
Pct From52w High
-15.62%
Pct From52w Low
114.23%

Related